About Us
Experience
We have proven international experience to deliver project on fast track basis and strict deadlines when other is ready to take it (24/7)
Quality
We guarantee quality if any observation of Regulatory Authority on our work, we will do it free of cost to close observations
Customers
Our customers include well know pharmaceutical industry and their satisfaction is our asset
Accuracy
Our experts have close contact with Regulatory Authority to know expectations and work accurately
Certificate
Our customer receive GMP Inspections Certificate – Right First Time
Templates
We have smart, ready to use templates and special tools to save time & costs to meet GMP requirements
Membership
Our team have membership in various leading professional associations to participate in their programs that keeps their knowledge up-to-date at high level
I love this company! The leaders are truly invested in each individual's growth and success. They care about the future of Pharma clients and invest time to help you to be successful. Another thing I love about this company is they don't shy away from feedback. They tell people what they need to know to be the best version of themselves and I really appreciate that.
Excellent consultant with vast experience in both Regulatory and Pharmaceutical Quality Systems arena: pragmatic scientists with high quality standards, resolved many issues...". able to manage and coach personnel effectively, shown tremendous commitment and dedication over and above what is expected from permanent staff members. They are well respected by the people in Pharmaceuticals for which they worked for....
The creation of GMP Compliance Academy will bring much needed knowledge know-how and information to Pharma industry across the world. The academy will provide guidance and clear the way for many those aspects of GMP that have historically been difficult to follow.
Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She has over 25 years experience working in the following Drug and Biotech Development: Phase 1 through Commercialization, Orphan products, Biosimilars, Generic drugs, Drug-Device Combinations.